FDA clears Sangamo to begin phase I/II study of its ZFP Therapeutic for beta-thalassemia Feb. 6, 2015 No Comments
FDA grants breakthrough therapy designation to LentiGlobin for beta-thalassemia major Feb. 3, 2015 No Comments
Biogen Idec, Fondazione Telethon and Ospedale San Raffaele collaborate on hemophilia gene therapies Jan. 29, 2015 No Comments
FDA approves Triferic for iron replacement and hemoglobin maintenance in CKD Jan. 27, 2015 No Comments
RSS